Delivery Order SPE2DB24D2101-SPE2DB25FKPAJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count packaging) with a ceiling value of $1,573.01. This firm fixed-price delivery order is scheduled for ultimate completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count packages) with a ceiling value of $1,150.23. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance of this contract is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Mucus Relief ER 600 mg tablets (500-count bottles) with a ceiling value of $1,195.33 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg with a ceiling value of $3,774.96. This non-set-aside, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed pricing terms. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,318.09 by the Defense Logistics Agency on August 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count containers). The contract is characterized as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was awarded on a competitive basis without set-aside designation. Performance will occur at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets in a quantity of 500 units, with a contract ceiling value of $1,206.30. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, valued at $2,271.04, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $1,641.44. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $1,106.16 to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPAJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $2,963.45. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a prime pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medical commodities including brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/28/25 |